Cristina C. B.
- Country
- Spain
- Department
- Servicio de Dermatologia
Research Overview
- A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Ritlecitinib in Adults with Moderate to Severe Hidradenitis Suppurativa
- A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of BFB759 in Patients with Moderate to Severe Hidradenitis Suppurativa
- Phase 3 Extension Study of Long-Term Safety and Efficacy of Remibrutinib in Adults With Moderate to Severe Hidradenitis Suppurativa
Data & Insights
Has run more than one trial at 110 of 217 partner sites.
Specializations
Dermatology and Inflammatory Skin Disease
The investigator is involved in clinical research on atopic dermatitis, hidradenitis suppurativa, and plaque psoriasis, with additional interest in chronic inflammatory skin disorders affecting both adult and pediatric populations.
- Atopic dermatitis
- Hidradenitis suppurativa
- Plaque psoriasis
- Chronic inflammatory skin disease
Clinical activity in this area reflects a focus on immune-mediated skin conditions and long-term symptom control in dermatologic care.
Breast Cancer and Solid Tumor Oncology
Research involvement extends across breast cancer, including HER2-positive, hormone receptor-positive, and triple-negative breast cancer, as well as broader solid tumors such as lung cancer, colorectal cancer, gastric cancer, and pancreatic cancer.
- HER2-positive breast cancer
- Hormone receptor-positive breast cancer
- Triple-negative breast cancer
- Metastatic solid tumors
The therapeutic profile includes interest in targeted and immuno-oncology strategies across advanced malignancies.
Hematologic Malignancies and Cell Therapy
The investigator participates in studies of lymphoma, multiple myeloma, leukemia, and myelodysplastic syndromes, with attention to relapsed, refractory, and newly diagnosed blood cancers. Work also includes CAR T-cell therapy and other advanced cellular approaches.
- Diffuse large B-cell lymphoma
- Multiple myeloma
- Acute myeloid leukemia
- CAR T-cell therapy
These activities align with therapeutic development in high-need hematology settings, including aggressive and treatment-resistant disease.
Autoimmune, Immune-Mediated, and Inflammatory Disorders
Clinical research includes systemic lupus erythematosus, lupus nephritis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and Crohn's disease, together with other immune-mediated diseases requiring targeted anti-inflammatory treatment.
- Systemic lupus erythematosus
- Lupus nephritis
- Psoriatic arthritis
- Inflammatory bowel disease
The therapeutic scope also includes chronic immune dysregulation and related multi-organ inflammatory conditions.
Liver, Metabolic, and Cardiovascular Disease
Additional research activity covers metabolic dysfunction-associated steatohepatitis, primary biliary cholangitis, hepatocellular carcinoma, obesity, type 2 diabetes, and cardiovascular disease, including heart failure and atherosclerotic disease.
- Metabolic liver disease
- Primary biliary cholangitis
- Obesity
- Heart failure
This portfolio shows involvement in therapeutic innovation across chronic hepatology, cardiometabolic risk, and organ-protective treatment strategies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.